https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-05-01 / Hepatol. Res. 2002 May;23(1):38-47
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-05-01 / Hepatol. Res. 2002 May;23(1):38-472002-05-01 00:00:002019-02-15 08:37:57Activation and maturation of antigen-presenting dendritic cells during vaccine therapy in patients with chronic hepatitis due to hepatitis B virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-05-01 / Int J Hyperthermia 2002 May-Jun;18(3):253-66
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-05-01 / Int J Hyperthermia 2002 May-Jun;18(3):253-662002-05-01 00:00:002019-02-15 09:17:54A phase I study of fever-range whole body hyperthermia (FR-WBH) in patients with advanced solid tumours: correlation with mouse models
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-05-01 / J. Clin. Oncol. 2002 May;20(9):2251-66
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-05-01 / J. Clin. Oncol. 2002 May;20(9):2251-662002-05-01 00:00:002019-02-15 09:22:28Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-05-01 / Br. J. Haematol. 2002 May;117(2):297-305
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-05-01 / Br. J. Haematol. 2002 May;117(2):297-3052002-05-01 00:00:002019-02-15 08:51:10Optimizing dendritic cell-based immunotherapy in multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-04-01 / Nihon Geka Gakkai Zasshi 2002 Apr;103(4):376-80
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-04-01 / Nihon Geka Gakkai Zasshi 2002 Apr;103(4):376-802002-04-01 00:00:002002-04-01 00:00:00[Immunotherapy for esophageal carcinoma]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-04-01 / Blood 2002 Apr;99(7):2512-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-04-01 / Blood 2002 Apr;99(7):2512-72002-04-01 00:00:002019-02-15 08:51:11Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-04-01 / Haematologica 2002 Apr;87(4):400-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-04-01 / Haematologica 2002 Apr;87(4):400-72002-04-01 00:00:002019-02-15 09:25:49Anti-idiotypic vaccination in the treatment of low-grade B-cell lymphoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-04-01 / Minerva Ginecol 2002 Apr;54(2):133-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-04-01 / Minerva Ginecol 2002 Apr;54(2):133-442002-04-01 00:00:002002-04-01 00:00:00Novel immunotherapeutic strategies in gynecologic oncology. Dendritic cell-based immunotherapy for ovarian cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-03-01 / Nat. Rev. Immunol. 2002 Mar;2(3):151-61
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-03-01 / Nat. Rev. Immunol. 2002 Mar;2(3):151-612002-03-01 00:00:002019-02-15 08:44:52Mouse and human dendritic cell subtypes
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-03-01 / J. Virol. 2002 Mar;76(6):3007-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-03-01 / J. Virol. 2002 Mar;76(6):3007-142002-03-01 00:00:002019-02-15 09:15:23Induction of anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) and CD4(+) T-cell reactivity by dendritic cells loaded with HIV-1 X4-infected apoptotic cells
